Cavalli F - Search Results

1

Phase I and clinical pharmacological evaluation of aphidicolin glycinate.

Sessa C, Zucchetti M, Davoli E, Califano R, Cavalli F, Frustaci S, Gumbrell L, Sulkes A, Winograd B, D'Incalci M. Sessa C, et al. Among authors: cavalli f. J Natl Cancer Inst. 1991 Aug 21;83(16):1160-4. doi: 10.1093/jnci/83.16.1160. J Natl Cancer Inst. 1991. PMID: 1886148 Clinical Trial.

2

Phase II study of intravenous menogaril in patients with advanced breast cancer.

Sessa C, Gundersen S, ten Bokkel Huinink W, Renard J, Cavalli F. Sessa C, et al. Among authors: cavalli f. J Natl Cancer Inst. 1988 Sep 7;80(13):1066-9. doi: 10.1093/jnci/80.13.1066. J Natl Cancer Inst. 1988. PMID: 2970554

3

Phase I study of the antifolate N10-propargyl-5,8-dideazafolic acid, CB 3717.

Sessa C, Zucchetti M, Ginier M, Willems Y, D'Incalci M, Cavalli F. Sessa C, et al. Among authors: cavalli f. Eur J Cancer Clin Oncol. 1988 Apr;24(4):769-75. doi: 10.1016/0277-5379(88)90313-6. Eur J Cancer Clin Oncol. 1988. PMID: 3383977

4

Clinical and pharmacokinetic study of oral NK611, a new podophyllotoxin derivative.

Pagani O, Zucchetti M, Sessa C, de Jong J, D'Incalci M, De Fusco M, Kaeser-Fröhlich A, Hanauske A, Cavalli F. Pagani O, et al. Among authors: cavalli f. Cancer Chemother Pharmacol. 1996;38(6):541-7. doi: 10.1007/s002800050524. Cancer Chemother Pharmacol. 1996. PMID: 8823496 Clinical Trial.

5

Phase I clinical and pharmacological study of oral methoxymorpholinyl doxorubicin (PNU 152243).

Sessa C, Zucchetti M, Ghielmini M, Bauer J, D'Incalci M, de Jong J, Naegele H, Rossi S, Pacciarini MA, Domenigoni L, Cavalli F. Sessa C, et al. Among authors: cavalli f. Cancer Chemother Pharmacol. 1999;44(5):403-10. doi: 10.1007/s002800050996. Cancer Chemother Pharmacol. 1999. PMID: 10501914 Clinical Trial.

6

Activity of aphidicolin glycinate alone or in combination with cisplatin in a murine ovarian tumor resistant to cisplatin.

Damia G, Tagliabue G, Zucchetti M, Davoli E, Sessa C, Cavalli F, D'Incalci M. Damia G, et al. Among authors: cavalli f. Cancer Chemother Pharmacol. 1992;30(6):459-64. doi: 10.1007/BF00685597. Cancer Chemother Pharmacol. 1992. PMID: 1394802

7

Phase II study of 5-aza-2'-deoxycytidine in advanced ovarian carcinoma. The EORTC Early Clinical Trials Group.

Sessa C, ten Bokkel Huinink W, Stoter G, Renard J, Cavalli F. Sessa C, et al. Among authors: cavalli f. Eur J Cancer. 1990 Feb;26(2):137-8. doi: 10.1016/0277-5379(90)90295-5. Eur J Cancer. 1990. PMID: 1691012 No abstract available.

8

Phase I study of the combination of monthly carboplatin and weekly cisplatin.

Sessa C, Goldhirsch A, Martinelli G, Alerci M, Imburgia L, Cavalli F. Sessa C, et al. Among authors: cavalli f. Ann Oncol. 1991 Feb;2(2):123-9. doi: 10.1093/oxfordjournals.annonc.a057874. Ann Oncol. 1991. PMID: 2054313 Free article. Clinical Trial.

9

Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group.

Sessa C, Kaye SB, Renard J, ten Bokkel Huinink W, Cavalli F. Sessa C, et al. Among authors: cavalli f. Eur J Cancer Clin Oncol. 1989 Apr;25(4):751-2. doi: 10.1016/0277-5379(89)90214-9. Eur J Cancer Clin Oncol. 1989. PMID: 2523809 No abstract available.

10

Dose-finding study of paclitaxel and cyclophosphamide in patients with advanced breast cancer.

Sessa C, Pagani O, Parma G, Goldhirsch A, Cavalli F. Sessa C, et al. Among authors: cavalli f. Semin Oncol. 1995 Jun;22(3 Suppl 6):112-7. Semin Oncol. 1995. PMID: 7541152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

642 results

Search Page

Filters